Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DX25F6VTE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $37,088
Award facts
- Contract value 100% obligated
- $37,087.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,087.67 for Repatha 140 mg/ml SureClick auto-injectors on September 25, 2025. This non-compete delivery order, which carries a firm fixed price structure and an ultimate completion date of September 26, 2025, was issued through the Medical Supply Chain, a defense-focused component of federal medical procurement. The contract represents a single transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a comprehensive $999.99 billion prime vendor vehicle designated SPE2DX and active through December 2026.
This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. Repatha (evolocumab) is a specialized PCSK9 inhibitor used for cholesterol management in eligible patients, reflecting the company's portfolio of specialty pharmaceutical products. The award was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements. The company's DLA prime vendor contract enables it to supply a broad range of pharmaceutical products, vaccines, and medical devices to support military healthcare operations globally, including service to the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DX25F6VTE?
SPE2DX25F6VTE was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 25, 2025.
How much is contract SPE2DX25F6VTE worth?
The government has obligated $37,088 on SPE2DX25F6VTE.
Is contract SPE2DX25F6VTE an order under another contract?
Yes. SPE2DX25F6VTE is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6VTE competed?
The extent of competition for SPE2DX25F6VTE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award